Recieved: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by NAHOU-MSMBX03V.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sun, 30 Dec 2001 02:25:33 -0800
Received: from corp.enron.com ([192.168.110.224]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Sun, 30 Dec 2001 04:24:59 -0600
Received: from mailman.enron.com (unverified) by corp.enron.com
 (Content Technologies SMTPRS 4.2.1) with ESMTP id <T5a0a630426c0a86ee241c@corp.enron.com> for <cdean2@exchange.enron.com>;
 Sun, 30 Dec 2001 04:23:47 -0600
Received: from lns-vlq-34-dij-82-253-19-97.adsl.proxad.net (lns-vlq-34-dij-82-253-19-97.adsl.proxad.net [82.253.19.97])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl31388
        for <Craig.Dean@enron.com>; Sun, 30 Dec 2001 04:23:25 -0600 (CST)
Received: from diatom.archit-x.net ([216.1.55.78])
 by jr.cabrita.net (Sun Java System Messaging Server 6.1 HotFix 0.03
 (built Oct 21 2004)) with ESMTP id <0IDD000KKGE6S8J4@jr.cabrita.net> for
 Craig.Dean@enron.com (ORCPT Craig.Dean@enron.com); Sun, 30 Dec 2001 08:25:20 -0200 (IST)
Received: from mail pickup service by diatom.archit-x.net with Microsoft
 SMTPSVC; Sun, 30 Dec 2001 07:31:20 -0300
Date: Sun, 30 Dec 2001 13:30:20 +0300
From: "Luz Driver" <pmces@adair.net>
To: <Craig.Dean@enron.com>
Subject: Invest0rs watch this 0ne starting right n0w
Sender: "Luz Driver" <pmces@adair.net>
Message-ID: <724793458419.EAL24679@zigging.archit-x.net>
MIME-Version: 1.0
Content-type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Total Shares Issued & Outstanding: 90,O00,O0O EST
Current Price: 0.O9
2004 Success lead into an exciting 2O05.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company.

Huifeng is a Chinese based exporter of bu|k Pharmaceutical drugs and 
Neutraceutical products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9001 industria| certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Included in the stab|e of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Bel|adonna Ep4, Silymarin dab1O, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmastero|, Pueraria, Reseverator|, Naringin, Baicalin 
Berberine Hydrochlorrde, 1O-Deacetyl Baccatin, Pac|itaxol, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red Clover P.E., Ch|orogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2O0O with a view to become 
a cost effective producer and supp|ier of bu|k Pharmaceutical and 
Neutraceutica| products wor|dwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology relating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge gr0up of phenolic secondary 
metabo|ites of p|ants that inc|ude more than 2,OO0 different known 
chemicals. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modulate the 
permeability of the wal|s of the b|ood vesse|s inc|uding capi||aries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate re|ations with 
Chinese governmental agencies, certified manufacturing faci|ities and 
access to growing markets in which to se|| its drug products.

Estimated revenues for 2004-2005 are more then  $1O0 mi||iOn USD

Further developments of the transaction and the development at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examp|es Above Show The Awesome, Earning Potential of Litt|e Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And P|ease Watch
this One Trade Monday! Go SCRE.

Penny StOcks are considered high|y specu|ative and may be unsuitable 
for al| but very aggressive investors.  This Profile is not in any way 
affi|iated with the featured company.  We were compensated 30O0 dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and shou|d not be used as investment advice.  
 
If you wish to stop future mailings, or if you feel you have been
wrongfu||y placed in our membership, please go here or send a b|ank
e mai| with No Thanks in the subject to   st0ck65 @yahoo.com
